Cubist Systematic Strategies’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $836K | Buy |
+2,983
| New | +$812K | ﹤0.01% | 2032 |
|
|
2024
Q2 | – | Sell |
-130
| Closed | -$45.1K | – | 3012 |
|
|
2024
Q1 | $45.1K | Sell |
130
-20,284
| -99% | -$6.67M | ﹤0.01% | 3393 |
|
|
2023
Q4 | $6.59M | Buy |
20,414
+18,543
| +991% | +$5.81M | 0.04% | 698 |
|
|
2023
Q3 | $671K | Sell |
1,871
-2,687
| -59% | -$1.04M | 0.01% | 2142 |
|
|
2023
Q2 | $1.73M | Sell |
4,558
-12,617
| -73% | -$5.13M | 0.01% | 1595 |
|
|
2023
Q1 | $8.23M | Sell |
17,175
-347
| -2% | -$162K | 0.05% | 570 |
|
|
2022
Q4 | $7.37M | Sell |
17,522
-4,098
| -19% | -$1.65M | 0.04% | 698 |
|
|
2022
Q3 | $9.02M | Buy |
21,620
+9,633
| +80% | +$4.8M | 0.05% | 557 |
|
|
2022
Q2 | $5.93M | Sell |
11,987
-13,131
| -52% | -$6.84M | 0.04% | 829 |
|
|
2022
Q1 | $14.1M | Buy |
25,118
+12,647
| +101% | +$7.62M | 0.12% | 158 |
|
|
2021
Q4 | $9.42M | Buy |
12,471
+6,153
| +97% | +$4.6M | 0.09% | 271 |
|
|
2021
Q3 | $4.71M | Buy |
6,318
+1,610
| +34% | +$1.21M | 0.06% | 490 |
|
|
2021
Q2 | $3.03M | Sell |
4,708
-6,826
| -59% | -$4.15M | 0.03% | 825 |
|
|
2021
Q1 | $6.59M | Buy |
11,534
+6,105
| +112% | +$3.62M | 0.08% | 315 |
|
|
2020
Q4 | $3.17M | Buy |
5,429
+2,929
| +117% | +$1.67M | 0.04% | 687 |
|
|
2020
Q3 | $1.29M | Sell |
2,500
-7,755
| -76% | -$3.93M | 0.02% | 1182 |
|
|
2020
Q2 | $4.63M | Buy |
10,255
+1,451
| +16% | +$640K | 0.08% | 384 |
|
|
2020
Q1 | $3.09M | Buy |
8,804
+6,552
| +291% | +$2.41M | 0.08% | 309 |
|
|
2019
Q4 | $833K | Sell |
2,252
-5,921
| -72% | -$2.09M | 0.02% | 1270 |
|
|
2019
Q3 | $2.72M | Sell |
8,173
-7,433
| -48% | -$2.42M | 0.05% | 503 |
|
|
2019
Q2 | $4.88M | Buy |
15,606
+10,947
| +235% | +$3.28M | 0.09% | 314 |
|
|
2019
Q1 | $1.42M | Buy |
4,659
+2,554
| +121% | +$689K | 0.05% | 588 |
|
|
2018
Q4 | $489K | Buy |
2,105
+1,905
| +953% | +$511K | 0.02% | 986 |
|
|
2018
Q3 | $63K | Sell |
200
-400
| -67% | -$124K | ﹤0.01% | 1675 |
|
|
2018
Q2 | $173K | Buy |
600
+133
| +28% | +$36.7K | 0.01% | 1402 |
|
|
2018
Q1 | $117K | Sell |
467
-4,945
| -91% | -$1.26M | 0.01% | 1561 |
|
|
2017
Q4 | $1.29M | Buy |
5,412
+2,597
| +92% | +$629K | 0.07% | 373 |
|
|
2017
Q3 | $626K | Buy |
+2,815
| New | +$633K | 0.04% | 683 |
|
|
2017
Q2 | – | Sell |
-801
| Closed | -$160K | – | 1678 |
|
|
2017
Q1 | $160K | Buy |
801
+145
| +22% | +$27.9K | 0.01% | 1266 |
|
|
2016
Q4 | $120K | Sell |
656
-2,093
| -76% | -$357K | 0.01% | 1434 |
|
|
2016
Q3 | $450K | Buy |
2,749
+475
| +21% | +$72.1K | 0.03% | 757 |
|
|
2016
Q2 | $325K | Buy |
+2,274
| New | +$324K | 0.02% | 1035 |
|
|
2016
Q1 | – | Sell |
-321
| Closed | -$45K | – | 1609 |
|
|
2015
Q4 | $45K | Sell |
321
-1,306
| -80% | -$181K | ﹤0.01% | 1604 |
|
|
2015
Q3 | $219K | Sell |
1,627
-120
| -7% | -$17.3K | 0.01% | 1416 |
|
|
2015
Q2 | $263K | Buy |
+1,747
| New | +$250K | 0.01% | 1294 |
|
Other funds holding BIO
VAM
AI
